Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828275) titled 'FASD Prevention R33' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Philadelphia College of Osteopathic Medicine
Condition:
Alcohol and Tobacco/Cannabis Use
Intervention:
Behavioral: Intervention
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: February 1, 2027
Target Sample Size: 184
Countries of Recruitment:
South Africa
To know more, visit https://clinicaltrials.gov/study/NCT07828275
Disclaimer: Curated by HT Syndication....